China Wholesale Ceramide Is Suppliers Factories - PromaCare-TA / Tranexamic Acid – Uniproma

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We insist about the theory of growth of 'High excellent, Performance, Sincerity and Down-to-earth working approach' to offer you with great company of processing for Vitamin E Sun Protect , Sun Cream For Hair , Uv Sunscreen Cream , We have experienced manufacturing facilities with more than 100 employees. So we can guarantee short lead time and quality assurance.
China Wholesale Ceramide Is Suppliers Factories - PromaCare-TA / Tranexamic Acid – Uniproma Detail:

Product Paramete

Trade name PromaCare-TA
CAS 1197-18-8
Product Name Tranexamic Acid
Chemical Structure
Application Medicine
Package 25kgs net per drum
Appearance White or almost white, crystalline power
Assay 99.0-101.0%
Solubility Water soluble
Shelf life 4 years
Storage Keep container tightly closed and in a cool place. Keep away from heat.

Application

Tranexamic Acid, also known as clotting acid, is an antifibrinolytic amino acid, which is one of the commonly used anticoagulants in clinic

This product can be used for:

1. Trauma or surgical bleeding of prostate, urethra, lung, brain, uterus, adrenal gland, thyroid, liver and other organs rich in plasminogen activator.

2. They are used as thrombolytic agents, such as tissue plasminogen activator (t-PA), streptokinase and urokinase antagonist.

3. Induced abortion, placental exfoliation, stillbirth and amniotic fluid embolism caused by fibrinolytic bleeding.

4. Menorrhagia, anterior chamber hemorrhage and severe epistaxis with increased local fibrinolysis.

5. It is used to prevent or reduce bleeding after tooth extraction or oral surgery in hemophilic patients with factor VIII or factor IX deficiency.

6. This product is superior to other antifibrinolytic drugs in hemostasis of mild hemorrhage caused by rupture of central aneurysm, such as subarachnoid hemorrhage and intracranial aneurysm hemorrhage. However, attention must be paid to the risk of cerebral edema or cerebral infarction. As for severe patients with surgical indications, this product can only be used as an adjuvant.

7. For the treatment of hereditary vascular edema, can reduce the number of attacks and severity.

8. Patients with hemophilia have active bleeding.

9. It has definite curative effect on chloasma.


Product detail pictures:

China Wholesale Ceramide Is Suppliers Factories - PromaCare-TA / Tranexamic Acid  – Uniproma detail pictures


Related Product Guide:

We thinks what customers think, the urgency of urgency to act during the interests of a purchaser position of theory, allowing for much better good quality, lower processing costs, prices are extra reasonable, won the new and old buyers the support and affirmation for China Wholesale Ceramide Is Suppliers Factories - PromaCare-TA / Tranexamic Acid – Uniproma, The product will supply to all over the world, such as: Brisbane, Saudi Arabia, belarus, Qualified R&D engineer might be there for your consultation service and we will try our best to meet your requirements. So you should feel free to contact us for inquiries. You'll be able to send us emails or call us for small business. Also you are able to come to our business by yourself to get further knowing of us. And we are going to surely present you with the best quotation and after-sale service. We're ready to build stable and friendly relations with our merchants. To achieve mutual success, we'll make our best efforts to build a solid co-operation and transparent communication work with our companions. Above all, we're here to welcome your inquiries for any of our merchandise and service.
  • Managers are visionary, they have the idea of "mutual benefits, continuous improvement and innovation", we have a pleasant conversation and Cooperation.
    5 Stars By Rosalind from Seychelles - 2018.07.12 12:19
    In our cooperated wholesalers, this company has the best quality and reasonable price, they are our first choice.
    5 Stars By Marian from St. Petersburg - 2017.09.30 16:36